Targeting enhanced neutralizing antibody responses via increased germinal center activity: early-phase vaccine trials with novel clinical designs
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting enhanced neutralizing antibody responses via increased germinal center activity: early-phase vaccine trials with novel clinical designs
Authors
Keywords
-
Journal
Current Opinion in HIV and AIDS
Volume 18, Issue 6, Pages 323-330
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2023-09-27
DOI
10.1097/coh.0000000000000826
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intrinsically determined turnover underlies broad heterogeneity in plasma-cell lifespan
- (2023) Marcus James Robinson et al. IMMUNITY
- Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma
- (2023) Jason R. Westin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of three dosing intervals for the primary vaccination of the SARS-CoV-2 mRNA Vaccine (BNT162b2) on magnitude, neutralization capacity and durability of the humoral immune response in health care workers: A prospective cohort study
- (2023) Darryl P. Leong et al. PLoS One
- Measles, mumps, and rubella revaccination in children after completion of chemotherapy and hematopoietic stem cell transplantation: a single-center prospective efficacy and safety analysis
- (2023) Min Wang et al. World Journal of Pediatrics
- SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study
- (2023) Joshua A. Hill et al. EClinicalMedicine
- A Regimen Compression Strategy for Commercial Vaccines Leveraging an Injectable Hydrogel Depot Technology for Sustained Vaccine Exposure
- (2023) Jerry Yan et al. Advanced Therapeutics
- Extended interval BNT162b2 vaccination enhances peak antibody generation
- (2022) Helen Parry et al. npj Vaccines
- Long-primed germinal centres with enduring affinity maturation and clonal migration
- (2022) Jeong Hyun Lee et al. NATURE
- Humoral and Cellular Responses to SARS-CoV-2 Vaccines Before and After Chimeric Antigen Receptor-Modified T Cell Therapy
- (2022) Michael A Gonzalez et al. Blood Advances
- Virus vaccines: proteins prefer prolines
- (2021) Rogier W. Sanders et al. Cell Host & Microbe
- Correlation between BNT162b2 mRNA Covid-19 vaccine-associated hypermetabolic lymphadenopathy and humoral immunity in patients with hematologic malignancy
- (2021) Dan Cohen et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Prise en charge prophylactique, thérapeutique des complications infectieuses et vaccination des patients traités par CAR-T cells : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)
- (2021) Franciane Paul et al. BULLETIN DU CANCER
- Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
- (2021) Rebecca P. Payne et al. CELL
- Strategies for induction of HIV‐1 envelope‐reactive broadly neutralizing antibodies
- (2021) Wilton B. Williams et al. Journal of the International AIDS Society
- A particulate saponin/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity
- (2021) Murillo Silva et al. Science Immunology
- Management of adults and children receiving CAR T-cell therapy: 2021 best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) and the European Haematology Association (EHA)
- (2021) P.J. Hayden et al. ANNALS OF ONCOLOGY
- A delayed fractionated dose RTS,S AS01 vaccine regimen mediates protection via improved T follicular helper and B cell responses
- (2020) Suresh Pallikkuth et al. eLife
- How we prevent infections in patients receiving CD19-targeted chimeric antigen receptor T-cells for B-cell malignancies
- (2020) Joshua A. Hill et al. BLOOD
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7)
- (2019) Catherine Cordonnier et al. LANCET INFECTIOUS DISEASES
- Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of Immunodominance
- (2019) Kimberly M. Cirelli et al. CELL
- The how’s and what’s of vaccine reactogenicity
- (2019) Caroline Hervé et al. npj Vaccines
- A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses
- (2019) Jon M. Steichen et al. SCIENCE
- Rapid Germinal Center and Antibody Responses in Non-human Primates after a Single Nanoparticle Vaccine Immunization
- (2019) Colin Havenar-Daughton et al. Cell Reports
- Overcoming Steric Restrictions of VRC01 HIV-1 Neutralizing Antibodies through Immunization
- (2019) K. Rachael Parks et al. Cell Reports
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches
- (2017) Matthias Pauthner et al. IMMUNITY
- How I vaccinate blood and marrow transplant recipients
- (2016) P. A. Carpenter et al. BLOOD
- Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies
- (2016) Bryan Briney et al. CELL
- CD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients
- (2016) Cameron J. Turtle et al. JOURNAL OF CLINICAL INVESTIGATION
- Fractional Third and Fourth Dose of RTS,S/AS01 Malaria Candidate Vaccine: A Phase 2a Controlled Human Malaria Parasite Infection and Immunogenicity Study
- (2016) Jason A. Regules et al. JOURNAL OF INFECTIOUS DISEASES
- Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination
- (2016) Hok Hei Tam et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunotherapy of non-Hodgkin’s lymphoma with a defined ratio of CD8 + and CD4 + CD19-specific chimeric antigen receptor–modified T cells
- (2016) Cameron J. Turtle et al. Science Translational Medicine
- Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice
- (2016) Andrew T. McGuire et al. Nature Communications
- Comparison of intramuscular and subcutaneous administration of a herpes zoster live-attenuated vaccine in adults aged ≥50 years: A randomised non-inferiority clinical trial
- (2015) Javier Diez-Domingo et al. VACCINE
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase I Randomized Clinical Trial of VRC DNA and rAd5 HIV-1 Vaccine Delivery by Intramuscular (IM), Subcutaneous (SC) and Intradermal (ID) Administration (VRC 011)
- (2014) Mary E. Enama et al. PLoS One
- Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
- (2011) David L. Porter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
- (2009) Marcie Tomblyn et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now